Cardiovascular Diseases Clinical Trial
Official title:
Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
Strong Teens for Healthy Schools (STHS) is a school-based, civic engagement program that empowers middle school students to improve their physical activity and healthy eating behaviors, improve their cardiovascular disease outcomes, and create positive change in their school health environments.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | April 15, 2027 |
Est. primary completion date | April 15, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years and older |
Eligibility | School Inclusion Criteria: - > 50 6th and 7th grade students - > 40% economically disadvantaged students - > 40% Black and Hispanic students School Exclusion Criteria: Student Inclusion Criteria: - 6th or 7th grade student - Attend a Title 1 middle school that is participating in the STHS intervention - Read and understand English Student Exclusion Criteria: - Participation in a weight loss program in the past 3 months - Presence of a condition that prevents participation in physical activity |
Country | Name | City | State |
---|---|---|---|
United States | Texas A&M AgriLife Dallas Center | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
Texas A&M University | National Institute on Minority Health and Health Disparities (NIMHD) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence or absence of metabolic syndrome (MetS) | MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels.
MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors) Measures to determine MetS risk factors: Abdominal obesity: waist circumference >90th percentile for child's sex and age High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg) High blood glucose: blood glucose =5.6 mmol/L or known diabetes Low HDL cholesterol: HDL cholesterol <1.03 mmol/L High triglyceride level: Triglyceride level = 1.7mmol/L |
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Primary | Change in the number of MetS risk factors | Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors)
Measures to determine MetS risk factors: Abdominal obesity: waist circumference >90th percentile for child's sex and age High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg) High blood glucose: blood glucose =5.6 mmol/L or known diabetes Low HDL cholesterol: HDL cholesterol <1.03 mmol/L High triglyceride level: Triglyceride level = 1.7mmol/L |
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Primary | Positive Youth Development score | Positive youth development will be measured using a 5 C's Model of Positive Youth Development Scale-Short Form (PYD-SF): A 34-item scale that assesses the strength of psychological, behavioral, and social development in youth.
The five dimensions measured are: Competence (sense of proficiency) Confidence (self-worth, self-efficacy) Character (adherence to societal and cultural rules) Connection (bonds with people and institutions) Caring (sympathy and empathy towards others) |
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Blood pressure level | Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Concentration of blood glucose | Glucose will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Waist circumference | Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Concentration of HDL cholesterol | HDL-C will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Concentration of serum triglycerides | Triglycerides will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Height | Height will be measured using a stadiometer in inches. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Weight | Weight will be measured with a scale in pounds. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Body mass index (BMI) | Weight will be measured with a scale, and height will be measured using a stadiometer. BMI will be calculated as BMI = (weight (lb)/height (inches)2) x 703. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Concentration of subdermal carotenoids | The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | Accelerometer-derived physical activity estimation | Physical activity will be measured using Actigraph accelerometers. Measurements will include light physical activity (PA), moderate PA, moderate to vigorous PA, and vigorous PA. | Baseline to 9 months | |
Secondary | Sedentary time | Sedentary time will be measured using Actigraph accelerometers. | Baseline to 9 months | |
Secondary | Time spent sleeping | Sleep time will be measured using Actigraph accelerometers. | Baseline to 9 months | |
Secondary | Physical fitness capacity estimation | Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness. | Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention | |
Secondary | School physical activity and nutrition environment assessment | The school's physical activity and nutrition environments will be measured using a self-reported School Environment Survey. | Baseline to 9 months | |
Secondary | Assessment of perceptions of school environments and school-specific dietary intake patterns | Perceptions related to physical activity and nutrition within the school setting will be measured using the Perceptions of the Environment and Patterns of Diet at School (PEA-PODS) survey. | Baseline to 9 months | |
Secondary | Assessment of perceived sociopolitical control | Perceived sociopolitical control will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' perceived sociopolitical control (i.e., participation in advocacy programs and optimism for change). | Baseline to 9 months | |
Secondary | Assessment of assertiveness | Assertiveness will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' assertiveness (i.e., ability to engage with adults and peers). | Baseline to 9 months | |
Secondary | Assessment of participatory competence and decision-making | Participatory competence and decision-making will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' participatory competence and decision-making (i.e., ability to influence group decision-making). | Baseline to 9 months | |
Secondary | Assessment of advocacy outcome efficacy | Advocacy outcome efficacy will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' advocacy outcome efficacy (i.e., belief in their ability to work with others to improve the school's physical activity and nutrition environment). | Baseline to 9 months | |
Secondary | Peer concentration of subdermal carotenoids | The concentration of subdermal carotenoids will assess peers' engagement in health behaviors changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy. | Baseline to 9 months | |
Secondary | Peer Body mass index (BMI) | Peers' engagement in health behaviors will be measured by the change in peers' BMI. Weight will be measured with a scale, and height will be measured using a stadiometer. Calculate BMI with the formula: BMI = (weight (lb)/height (inches)2) x 703. | Baseline to 9 months | |
Secondary | Peer physical fitness capacity estimation | Peers' engagement in health behaviors will be measured by the change in peers' physical fitness. Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness. | Baseline to 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|